It’s been a good year financially for retailers and automakers, despite the pandemic and microchip shortage.
The same can’t be said for many parts suppliers, however.
Average dealership profits have soared this year and have broken annual records. Automakers such as General Motors and Ford Motor Co. brought in billions of dollars in third-quarter profit, despite producing a fraction of the vehicles they would have liked.
While low inventories have given manufacturers and dealers plenty of headaches, margins on new-vehicle sales have risen as incentives plunged and consumers became willing to pay more to get their hands on a vehicle. That, in turn, has given automakers and dealers plenty of financial cushion over the last year even as sales plummeted.
But for suppliers, whose business models revolve around supplying vehicle components to automakers at fixed costs, the situation has been remarkably different.
Suppliers have been feeling the financial pain as the assembly plants they supply worldwide produce millions fewer vehicles than they normally would.
Lear Corp., the world’s ninth-largest auto parts supplier, this month reported a loss of $27 million in the third quarter, compared with $174 million in net income a year earlier, as decreased vehicle production took a bite out of the company’s finances.
On a call with investors this month, Lear CEO Ray Scott pointed out unpredictability as the problem.
“Our financial results were negatively impacted not only by significant volume reductions versus last year,” Scott said, “but also by low visibility from our customers leading to short-notice production shutdowns.”
Similarly, Canadian giant Magna International Inc., North America’s largest supplier, reported net income of $11 million for the third quarter, a 97 percent plunge from the $405 million it made a year earlier.
Cooper-Standard Automotive Inc. said it had a $123.2 million net loss in the third quarter. In response to the situation, CEO Jeff Edwards told investors that it is renegotiating contracts with customers, with the goal of recovering $100 million in losses.
“We’ve asked for recoveries starting October 1st,” Edwards said. “Obviously, we can ask whatever we want to, and we’re in the stage of negotiation where in some cases, we’ve achieved that. In other cases, the negotiations are still ongoing.”
where to buy ivermectin – ivermectin 12 mg over the counter buy carbamazepine sale
order generic isotretinoin 40mg – order isotretinoin 20mg zyvox 600mg sale
brand amoxil – buy generic amoxicillin buy ipratropium 100 mcg online cheap
purchase azithromycin online – zithromax 250mg without prescription nebivolol 5mg usa
cheap omnacortil pills – cost progesterone 100mg buy progesterone 200mg pills
buy generic augmentin online – duloxetine 40mg over the counter cheap cymbalta 20mg
order doxycycline for sale – buy glipizide generic glipizide medication
cheap augmentin 1000mg – buy ketoconazole without a prescription buy cymbalta pills for sale
buy zanaflex tablets – buy zanaflex for sale oral hydrochlorothiazide 25 mg
how much is cialis – buy sildenafil online sildenafil dosage
viagra for women – cialis ca order generic cialis 5mg
atorvastatin 20mg oral – buy lisinopril 10mg without prescription lisinopril 2.5mg generic
cenforce 50mg price – purchase chloroquine online cheap buy glycomet 500mg pill
prilosec 20mg us – purchase prilosec generic atenolol where to buy
medrol 4 mg oral – buy triamcinolone for sale generic triamcinolone
buy clarinex 5mg pills – claritin medication buy priligy 60mg for sale
purchase cytotec for sale – buy misoprostol no prescription buy generic diltiazem for sale